☰

Stephen M. Eggan, Ph.D. - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Schizophrenia; structure, function and development of prefrontal cortex; effects of cannabis and psychotropic medications on neural circuitry
Tree Info Grants Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Volk DW, Eggan SM, Horti AG, Wong DF, Lewis DA. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia Research. 159: 124-9. PMID 25107849 DOI: 10.1016/J.Schres.2014.07.017  0.78
2013 Curley AA, Eggan SM, Lazarus MS, Huang ZJ, Volk DW, Lewis DA. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Disease. 50: 179-86. PMID 23103418 DOI: 10.1016/J.Nbd.2012.10.018  0.769
2012 Eggan SM, Lazarus MS, Stoyak SR, Volk DW, Glausier JR, Huang ZJ, Lewis DA. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biological Psychiatry. 71: 114-9. PMID 22036037 DOI: 10.1016/J.Biopsych.2011.09.014  0.759
2010 Volk DW, Eggan SM, Lewis DA. Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The American Journal of Psychiatry. 167: 1489-98. PMID 20889653 DOI: 10.1176/Appi.Ajp.2010.10030318  0.805
2010 Eggan SM, Stoyak SR, Verrico CD, Lewis DA. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2060-71. PMID 20555313 DOI: 10.1038/Npp.2010.75  0.766
2010 Eggan SM, Melchitzky DS, Sesack SR, Fish KN, Lewis DA. Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience. 169: 1651-61. PMID 20542094 DOI: 10.1016/J.Neuroscience.2010.06.011  0.512
2010 Eggan SM, Mizoguchi Y, Stoyak SR, Lewis DA. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 20: 1164-74. PMID 19703937 DOI: 10.1093/Cercor/Bhp179  0.579
2008 Eggan SM, Hashimoto T, Lewis DA. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry. 65: 772-84. PMID 18606950 DOI: 10.1001/Archpsyc.65.7.772  0.783
2007 Eggan SM, Lewis DA. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cerebral Cortex (New York, N.Y. : 1991). 17: 175-91. PMID 16467563 DOI: 10.1093/Cercor/Bhj136  0.53
2005 Melchitzky DS, Eggan SM, Lewis DA. Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience. 130: 185-95. PMID 15561434 DOI: 10.1016/J.Neuroscience.2004.08.046  0.522
2004 Lewis DA, Cruz D, Eggan S, Erickson S. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia Annals of the New York Academy of Sciences. 1021: 64-76. PMID 15251876 DOI: 10.1196/Annals.1308.008  0.766
2004 Cruz DA, Eggan SM, Azmitia EC, Lewis DA. Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. The American Journal of Psychiatry. 161: 739-42. PMID 15056522 DOI: 10.1176/Appi.Ajp.161.4.739  0.638
2003 Cruz DA, Eggan SM, Lewis DA. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. The Journal of Comparative Neurology. 465: 385-400. PMID 12966563 DOI: 10.1002/Cne.10833  0.563
2003 Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6315-26. PMID 12867516 DOI: 10.1523/Jneurosci.23-15-06315.2003  0.79
2003 Hashimoto T, Volk D, Eggan S, Pierri J, Sun Z, Sampson A, Lewis D. Altered gene expression in parvalbumin-containing GABA neurons in the prefrontal cortex of subjects with schizophrenia Schizophrenia Research. 60: 71. DOI: 10.1016/S0920-9964(03)80597-2  0.793
Show low-probability matches.